DiagnoCine offers excellent MdmX | phospho-MdmX (pSer367) Phosphorylated Antibodies for the researchers studying Cell Growth & Survival, Therapeutic Target in Cancers, Cell Cycle, DNA Repair, Lipid Remodelling, Endocrine Pancrease development, Ferrosptosis, and Therapeutic Target in Hepatocellular Carcinoma.
Human diseases include Lung Cancer, Breast cancer, Retinoblastoma, Leukemia, and Psychiatric disorder.
MdmX |MdmX (pSer367) Phosphorylated Antibodies has excellent quality and this highly pure antibody can be adapted for Western Blots, ELISA, Immunohistochemistry, and Immunoprecipitation with optimization.
General Information
| Cat. No. | :FNK-71-141 |
| Size | :50 ug |
| Antigen | :Human |
| Host Species | :Mouse |
| Cross Reactivity | :Human/ Mouse |
| Label | :Unlabeled |
| Clone | :15 |
| Product | :Mouse monoclonal antibody (clone #15) specific to the MdmX protein phosphorylated at Ser367 |
| Immunogen | :A synthetic peptide corresponding to a sequence of human Mdmx protein surrounding phospho-Ser367 |
| Reaction | :Human and mouse MdmX proteins phosphorylated at Ser367 |
| Form | :Purified monoclonal antibody(IgG)1 mg/ml in PBS (-), 50% glycerol |
| Isotype | :Mouse IgG2b (κ) |
| Application | :
|
| Data Link | :UniProtKB/Swiss-Prot O15151 (MDM4_HUMAN) |
Description
MdmX (synonyms: Mdm4, HdmX) inhibits p53-and p73-dependent cell cycle arrest and apoptosis by binding to the transcription activation domains of these proteins. MdmX consists of 490 amino acids with the molecular weight of 54,864 and contains a RIING-finger domain and a nuclear transport signal. It is known that the protein migrates aberrantly in SDS-PAGE at the position of an 80-kDa protein. MdmX is phosphorylated at Ser367 by Chk2 kinase downstream of ATM in response to DNA damage, and as a result, it binds to14-3-3 and is transported into nucleus where it is degraded by Mdm2. This process activates the p53 functions.

Figure. Induction of S367 phosphorylation after DNA damage is associated with increased binding of 14-3-3 to MdmX and accelerated MdmX degradation.
MCF cells were preincubated with the proteasome inhibitor MG132 (20 uM) and exposed to DNA damaging agent, adriamycin (3 uM) or etoposide (20 uM), for the indicated periods. The cell lysates were used for immunoprecipitation with anti-MdmX antibody (D-19, Santa-Cruz) and The MdmX immunoprecipitates and the total lysate were analyzed by Western blotting using the indicated antibodies including this product (anti P-S367).
Aliases for MDM4 Gene
References
